Add Company
Join Now

Alpha-9 Oncology Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

#8493

Growjo Ranking

Biotech

Industry
Embed

Estimated Revenue & Valuation

  • Alpha-9 Oncology's estimated annual revenue is currently $7M per year.(i)
  • Alpha-9 Oncology's estimated revenue per employee is $155,000

Employee Data

  • Alpha-9 Oncology has 45 Employees.(i)
  • Alpha-9 Oncology grew their employee count by 73% last year.

Alpha-9 Oncology's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Alpha-9 Oncology?

Alpha-9 Oncology is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer. Applying proprietary technologies and deep-foundational expertise, Alpha-9 is on the forefront of engineering bespoke radiopharmaceuticals that are optimized to selectively deliver radiation to tumor sites while minimizing off-target effects. Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several validated oncology targets. Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of improving the lives of patients affected by metastatic cancers.

keywords:N/A

N/A

Total Funding

45

Number of Employees

$7M

Revenue (est)

73%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M45-56%N/A
#2
$5.2M45N/AN/A
#3
$7.9M455%N/A
#4
$5.2M45-2%N/A
#5
$6.5M45-4%N/A